Position in CPRX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$9,438,091
+$8,391,023 QoQ
Shares Held
381,183
+659.8% QoQ
Ownership
0.311%
of shares outstanding
% of Portfolio
2.66%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Advisors Preferred, LLC holds $10,798,908 across 2 Biotechnology names. CPRX ranks #1 (87.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CPRX |
Catalyst Pharmaceuticals, Inc.
This page
|
381,183 | $9,438,091 | |
| 2 | GMAB |
Genmab A/S
|
50,720 | $1,360,817 |
All Filings in CPRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,438,091 | 381,183 | Shares | Other | 2026-05-05 | |
| 2024-12-31 | $1,047,068 | 50,171 | Shares | Other | 2025-01-28 | |
| No filing history on record for this holder in this stock. | ||||||